{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-046335","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2023-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.772635+00:00","generated_at":"2026-06-10T06:19:15.418371+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ADMA Biologics appoints Alison C. Finger to board as Class I director","bullets":["Alison C. Finger appointed to board effective Sept 28, 2023; term expires at 2026 annual meeting.","Ms. Finger was Chief Commercial Officer at bluebird bio (Aug 2015-Jan 2021) and held VP roles at BMS.","Initial grant of options to purchase 98,870 shares of common stock upon joining the board.","No arrangements or transactions requiring disclosure under Item 404(a) exist."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-046335","json":"https://secwatch.observer/filing/0001140361-23-046335.json","markdown":"https://secwatch.observer/filing/0001140361-23-046335.md","text":"https://secwatch.observer/filing/0001140361-23-046335.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123046335/0001140361-23-046335-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123046335/ef20011676_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:19:15.418371+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6144721e19","claim":"Alison C. Finger was appointed as Class I director at ADMA BIOLOGICS, INC..","evidence_excerpt":"On September 28, 2023, the Board of Directors (the “Board”) of ADMA Biologics, Inc. (the “Company”) appointed Alison C. Finger to serve on the Board as a Class I director with a term expiring at the Company’s 2026 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123046335/0001140361-23-046335-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}